Advocate Group’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Hold
31,950
0.03% 117
2026
Q1
$279K Hold
31,950
0.04% 108
2025
Q4
$160K Hold
31,950
0.03% 123
2025
Q3
$198K Hold
31,950
0.03% 122
2025
Q2
$69.7K Hold
31,950
0.01% 119
2025
Q1
$70.3K Hold
31,950
0.01% 114
2024
Q4
$56.6K Hold
31,950
0.01% 115
2024
Q3
$24.4K Hold
31,950
﹤0.01% 118
2024
Q2
$10.7K Hold
31,950
﹤0.01% 121
2024
Q1
$7.99K Hold
31,950
﹤0.01% 122
2023
Q4
$7.96K Hold
31,950
﹤0.01% 116
2023
Q3
$11.8K Hold
31,950
﹤0.01% 117
2023
Q2
$10.1K Hold
31,950
﹤0.01% 116
2023
Q1
$12.1K Hold
31,950
﹤0.01% 119
2022
Q4
$15.6K Hold
31,950
﹤0.01% 116
2022
Q3
$12K Hold
31,950
﹤0.01% 112
2022
Q2
$13K Buy
+31,950
New +$13.9K ﹤0.01% 111

Other funds holding UAMY

Advocate Group's UAMY Position: Q2 2026 in Review

Advocate Group held its United States Antimony (UAMY) position steady in Q2 2026 at 31,950 shares worth $232K. The position accounts for 0.03% of the portfolio, ranked #117.

Advocate Group first reported a position in UAMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $279K in Q1 2026. 71 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • Advocate Group held 31,950 shares of United States Antimony worth $232K as of Q2 2026.
  • Advocate Group left its United States Antimony share count unchanged in Q2 2026.
  • United States Antimony made up 0.03% of Advocate Group's portfolio in Q2 2026, its #117 holding.
  • Advocate Group first reported a position in United States Antimony in Q2 2022 and has held it in 17 quarters since.
  • Advocate Group's United States Antimony position peaked at $279K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.